knowledge -WSS

knowledge

author：entertainment 2025-09-30 11:06:28 - browse：6165

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The Danish pharmaceutical company Novo Nordisk has shepherded all kinds of medical innovation in the 110 years since it was founded. But the booming success of its diabetes and obesity drug is unlike anything executives have seen before.

The company’s mid-year operating profit jumped from 37.5 billion Danish kroner in 2022 to 48.9 billion Danish kroner this year — “probably the strongest growth in the history of the company,” Chief Financial Officer Karsten Munk Knudsen said during an August earnings call. The 30% growth rate came from sales of semaglutide, which Novo Nordisk sells for diabetes under the name Ozempic and for obesity as Wegovy.

With its new blockbuster drug in hand, Novo Nordisk is valued higher than the entire economy of Denmark, where it’s based.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Resistance to opioid

WSS

ACIP vaccine advisory panel sees its vacancies filled

Artificial intelligence use in health care faces greater scrutiny in 2024

Latigo launches with $135 million for Vertex

Microsoft's Peter Lee: Generative AI could help doctors be more human

Readout Newsletter: BridgeBio, Akero, and human embryo models

Families look for replacement for GSK asthma drug Flovent

knowledge

knowledge

explore

In age of alternative facts, a scholarly course on calling out crap

The public health thinking behind the CDC’s new Covid guidance

Drug repurposing or repositioning? The language matters

IVF doctors demand details after CooperSurgical lawsuit

Moonlake's readout produced a cash windfall. Risks remain

Biden's 'march

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Medicare details structure of new drug price negotiation program

Longer MASH drug regimen improved liver, Akero study finds

focus

Ebola vaccine can save some who are already sick, per new study

Fetal cell organoids grown from amniotic fluid, study finds

Study gives hint on South Asians’ higher risk of cardiovascular disease

Study gives hint on South Asians’ higher risk of cardiovascular disease

Congress might make insulin pumps more accessible to the blind

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

explore

knowledge

focus

explore